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Post-translational Processing of the Glycoproteins of Lymphocytic Choriomeningitis Virus 
K. E. WRIGHT,’ R. C. SPIRO,‘J. W. BURNS, AND M. J. BUCHMEIER3 
Department of Neuropharmacology, Research Institute of Scripps Clinic, La /o//a, California 92037 
Received April 25, 1989; accepted March 14. 1990 
Intracellular events in the synthesis, glycosylation, and transport of the lymphocytic choriomeningitis virus (LCMV) 
glycoproteins have been examined. We have shown by N-glycanase digestion that LCMV strain Arm-4 bears five oligo- 
saccharides on GP-1 and two on GP-2. By pulse-chase labeling experiments in the presence of drugs which inhibit N- 
linked oligosaccharide addition and processing we demonstrate that addition of high mannose precursor oligosaccha- 
rides is necessary for transport and cleavage of the viral GP-C glycoprotein. Moreover, in the presence of tunicamycin 
which inhibits en bloc addition of these mannose-rich side chains, virus budding was substantially decreased and 
infectious virions were reduced by more than lOOO-fold in the supernatant medium. Incubation in the presence of 
castantospermine, which permits addition of oligomannosyl-rich chains but blocks further processing, restored trans- 
port and cleavage of GP-C and maturation of virions. Finally, by temperature block experiments we have determined 
that maturation of GP-C oligosaccharides to an endoglycosidase H resistant form precedes cleavage to GP-1 and 
GP-2. The latter process is most likely to occur in the Golgi or post-Golgi compartment. o 1990AcademicPress, IW. 
INTRODUCTION 
Lymphocytic choriomeningitis virus (LCMV), the pro- 
totype member of the Arenaviridae, has provided inves- 
tigators with a wealth of information about virus-host 
interaction. In the mouse, LCMV can establish a range 
of diseases from acute, lethal choriomeningitis to life- 
long persistent infection. Through the study of these 
diseases several fundamental concepts have evolve-d 
including tolerance and immune complex disease (re- 
viewed in Buchmeier et al., 1980), virus alteration of 
specialized or luxury functions of differentiated cells 
(Oldstone et a/., 1984; Klavinskis et a/., 1988) and the 
requirement for major histocompatability complex in 
expression of antiviral cytotoxic T-cell killing and virus 
clearance (Zinkernagel and Doherty, 1974; Zinkernagel 
and Welsh, 1976). 
The structure of LCMV is the best characterized of 
the arenaviruses. There are three major structural pro- 
teins, a nucleocapsid protein (NP, 1\/1,63 kDa), and two 
glycoproteins, GP-1 (AI, 44 kDa) and GP-2 (n/l, 35 kDa). 
In addition, there are at least two quantitatively minor 
proteins, L (M, 200 kDa) which is presumed to be a viral 
RNA dependent RNA polymerase, and a minor l2- 
14,000 M, polypeptide, termed Z, which may consti- 
tute a zinc binding protein (Salvato et al., 1989; Buch- 
meier and Parekh, 1987). Glycoproteins GP-1 and GP-2 
are post-translationally cleaved from a cell-associated 
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mannose-rich precursor, GP-C (n/r, 75-76 kDa) (Buch- 
meier and Oldstone, 1979). Most of our work to date 
has focused on the antigenic structure of these glyco- 
proteins. The major glycoprotein, GP-1, has at least 
four B-cell epitopes, two of which bind neutralizing anti- 
bodies. GP-2 has three overlapping epitopes (Parekh 
and Buchmeier, 1986) of which two are conserved 
among the arenaviruses (Weber and Buchmeier, 1988; 
Buchmeieretal., 1981). 
Little is known about post-translational processing of 
arenavirus glycoproteins. The proteolytic cleavage site 
of GP-C is apparently a paired basic amino acid se- 
quence, Arg-Arg at amino acids 262-263 (Buchmeier 
et al., 1987) and cleavage is mediated by a cellular pro- 
tease. A similar precursor glycopeptide has also been 
identified for Pichinde (Harnish et a/., 1981) Lassa 
(Clegg and Lloyd, 1983) and Tacaribe viruses (Gi- 
menez eta/., 1983; Franz-Fernandez et a/., 1987); how- 
ever, Tacaribe contains only one structural glycopro- 
tein. 
An understanding of the biosynthesis, processing, 
and transport of the LCMV glycoproteins may aid in in- 
terpreting aspects of the viral biology. For example, in 
persistent LCMV infections selective modulation of gly- 
coprotein expression has been reported in infected 
cells (Welsh and Buchmeier, 1979) and tissues (Old- 
stone and Buchmeier, 1982), but the mechanism of 
regulation remains unclear. Moreover, recent studies 
have described cytotoxic T-cell epitopes on the glyco- 
proteins of LCMV (Whitton et a/., 1988). Based on cur- 
rent knowledge of the role of class I MHC in the endog- 
enous pathway of antigen presentation, it is likely that 
association between class I and glycoprotein or a frag- 
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ment derived from it occurs within the intracellular 
transport pathway. Finally, little is known about interac- 
tion between the LCMV glycoproteins and cell-surface 
viral receptors and the mechanism of viral entry into 
cells. Studies reported here address two basic aspects 
of post-translational processing of LCMV: N-linked gly- 
cosylation of the glycoproteins, and requirements for 
and kinetics of subsequent transport, trimming and 
proteolytic cleavage of GP-C, GP-1 and GP-2. 
MATERIALS AND METHODS 
Virus and cell culture 
The virus used throughout these experiments, 
LCMV Armstrong clone 4 (Arm-4) was plaque purified 
from a stock of Armstrong CA-1 37 1 (Parekh and Buch- 
meier, 1986; Wright et a/., 1989). Working stocks were 
prepared by infecting BHK-21 cells at a multiplicity of 
infection (m.o.i.) of 0.1 and harvesting the supernatants 
48 hr later. Virus was purified by polyethylene glycol 
precipitation followed by banding on 1 O-40% (v/v) re- 
nograffin-76 (Squibb Diagnostics) gradients (Buch- 
meier and Oldstone, 1979). 
Glycosylation inhibitors 
Tunicamycin (TUN), deoxymannojirimycin (DMJ), and 
swainsonine (SSN) were purchased from Boehringer- 
Mannheim, and castanospermine (CSP) and /V-methyl- 
deoxynojirimycin (NM-DNJ) from Genzyme. Stock solu- 
tions of TUN were prepared in DMSO. Stock solutions 
of DMJ, SSN, and NM-DNJ were prepared in culture 
medium. In immunofluorescence experiments inhibi- 
tors were added at the time of infection and maintained 
for the duration. For metabolic labeling, inhibitors were 
added to infected cultures for 24 hr before labeling and 
retained throughout the labeling and chase periods. 
Optimal drug concentrations used were predetermined 
by titration of their inhibitory activity in BHK-21 cells. 
Concentrations used were TUN, 0.5 pg/ml; CSP, 80 
pg/ml; NM-DNJ, 2 mM; DMJ, 2 mM; SSN, 0.5 pg/ml. 
Control cultures for TUN were incubated in the pres- 
ence of equivalent concentrations of DMSO. 
lmmunofluorescence 
Indirect immunofluorescence of permeabilized cells 
was done on BHK-21 cell coverslips infected 24 hr ear- 
lier at an m.o.i. of 1 .O (Buchmeier et a/., 1981). For sur- 
face immunofluorescence, infected BHK cells were 
trypsinized, then stained with anti-LCMV monoclonal 
antibodies (MAb) and fluorescein-labeled sheep anti- 
mouse IgG. Other studies have established that LCMV 
antigens on the surfaces of infected cells resist trypsin 
treatment (Buchmeier et al., 1981). 
lmmunoprecipitation and polyactylamide gel 
electrophoresis (PAGE) 
BHK-21 cells were infected at an m.o.i. of 1 .O for 48 
hr, then pulse labeled for 1 hr in methionine-free Dul- 
becco’s medium (Flow Laboratories) containing 60 
&i/ml L-[35S]methionine (Amersham). Cells were pre- 
treated for 24 hrwith glycosylation inhibitors at the indi- 
cated concentrations in methionine-free media before 
labeling. Cells were chased as indicated in medium 
containing glycosylation inhibitors and a IO-fold ex- 
cess of cold L-methionine. Lysates were prepared in a 
buffer containing 20 mM Tris, 137 mh/l NaCI, 1 mM 
CaCI,, 0.5 mM MgCI,, 1% (v/v) NP-40, 10% (v/v) glyc- 
erol, and 1% (v/v) aprotinin, then cleared by centrifuga- 
tion at 14,000 rpm for 15 min. Cell equivalents of con- 
trol and test lysates were incubated with antibody at a 
final dilution of 1:500 for 45-60 min at 22”, after which 
80 ~1 of washed protein A-Sepharose CL-4B beads 
(Sigma) were added. Tubes were incubated for 30 min 
with continuous shaking, then precipitates were col- 
lected by centrifugation and washed three times in 
wash buffer (100 ml\/l Tris, 500 mM LiCI) before resus- 
pending in 20 ~1 buffer containing 1% 2-ME, 2% SDS. 
Endoglycosidase H (EH) digestion was done on im- 
mune-precipitated viral proteins. Briefly, each precipi- 
tated sample was digested for 2 hr at 37” with 0.005 
units of EH. Samples were heated to 100” for 2 min, 
then loaded onto 10% polyacrylamide gels (Laemmli, 
1970). 14C-methylated protein markers (Amersham) 
were run on each gel. After electrophoresis gels were 
fixed in 7% acetic acid, 20% methanol, washed with 
distilled water, incubated in Autofluor (National Diag- 
nostics) for 30 min, then dried and exposed to film at 
-70”. For temperature block experiments, chases 
were carried out at the indicated temperatures in indi- 
vidual water baths. 
Western blotting 
Purified virus (200 pg) was digested with 0.5 units 
peptide AI-glycosidase F (PNGF), a gift from Dr. J. Elder, 
Scripps Clinic and Research Foundation, for varying 
lengths of time to remove N-linked carbohydrates. 
Samples were then separated by SDS-PAGE, electro- 
phoretically transferred to nitrocellulose, and immu- 
noblotted with MAb specific for either GP-1 (67.5) or 
GP-2 (33.6). 
Electron microscopy 
Virus-infected and uninfected control monolayer cul- 
tures of BHK-21 cells were detached by scraping with a 
rubber policeman, then pelleted at 500 g. Pellets were 
fixed in 2.5010 buffered glutaraldehyde and epon em- 
bedded. Thin sections were prepared, stained with os- 
mium tetroxide, and examined in an Hitachi electron 
microscope. 
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FIG. 1. Enumeration of oligosaccharide side chains on the LCMV 
GP-1 and GP-2 glycoproteins. Purified LCMV Arm-4 was digested 
with PNGF as described under Materials and Methods. Samples of 
the digest were removed immediately after adding all reagents (0 
time) and at 2, 4, and 24 hr as indicated. Polypeptides were resolved 
on 10% (A) or 12.5% (6) SDS-PAGE gels and viral proteins visualized 
by Western blotting using GP-1 -specific (MAb 67.5) or GP-2specific 
(MAb 33.6) MAb. 
RESULTS 
Glycosylation of the major glycoprotein of LCMV 
We have previously observed that the precursor mol- 
ecule, GP-C, was labeled heavily with 2-j3H]mannose, 
whereas the mature GP-1 and GP-2 glycoproteins con- 
tained relatively little mannose but were labeled with 
[3H]galactose and [3H]fucose (Buchmeier and Old- 
stone, 1979; Buchmeier and Parekh, 1987). These re- 
sults suggested that GP-C contained high mannose oli- 
gosaccharides which were trimmed to a complex form 
prior to post-translational proteolytic cleavage to GP-1 
and GP-2. In order to determine the extent of glycosyla- 
tion of each glycoprotein, purified virus was digested 
with PNGF for various intervals before separation by 
SDS-PAGE and Western blotting with GP-l- or GP-2- 
specific antisera. Digestion produced a ladder of bands 
representing polypeptide chains with successively 
fewer oligosaccharide side chains. By this method we 
were able to demonstrate a total of six bands which 
reacted with GP-1 antibody, indicating that Arm-4 GP- 
1 contained five N-linked carbohydrates (Fig. 1 A). One 
of these bands, labeled -1 on Fig. 1 A, was present only 
momentarily after addition of PNGF and comigrated 
with the fastest migrating portion of the undigested GP- 
1 band, suggesting that native GP-1 may actually be a 
mixture of polypeptide core chains with four and five 
oligosaccharides. 
Duration between synthesis and cleavage of GP-C 
In order to estimate the time between synthesis and 
cleavage of GP-C, replicate cultures were pulsed for 5 
min with [35S]Met, then chased for intervals of 15, 30, 
60, 90, 120, 180, 270, or 360 min before immunopre- 
cipitation with antibody to GP-2. The results of such a 
pulse-chase experiment are illustrated in Fig. 2. GP-C 
was evident immediately after pulsing but GP-2, indica- 
tive of GP-C cleavage, was not evident until 90 min 
chase had elapsed. In additional experiments focusing 
on the 60-to 120-min chase interval we have observed 
the first appearance of GP-2 at 75 min (data not 
shown). 
Post-translational cleavage of GP-C requires 
prior glycosylation 
In experiments carried out to characterize the two 
neutralizing epitopes on GP-1, it was found that folding 
of the GP-C precursor required N-linked glycosylation 
(Wright et a/., 1989). In order to investigate the role of 
glycosylation in post-translational processing, we uti- 
lized the glycosylation inhibitors TUN, DMJ, SSN, CSP, 
and NM-DNJ to examine the requirement for N-linked 
glycosylation in more detail. BHK-21 cells were in- 
fected with Arm-4, then incubated with the indicated 
inhibitor for 24 hr prior to pulse labeling for 1 hr with 
[35S]methionine. Labeled cells were then chased in the 
presence of drug for 4 hr and immunoprecipitated with 
MAb 33.6 as above. In the presence of TUN there was 
only a slight reduction of the band representing ungly- 
cosylated GP-C and no concomitant appearance of a 
faster migrating band indicative of unglycosylated GP- 
2. We next examined the effect of inhibition of oligosac- 
charide trimming on cleavage using the inhibitors CSP, 
NM-DNJ, DMJ, and SSN. CSP and NM-DNJ inhibit glu- 
cosidases I and II and prevent trimming of terminal glu- 
cose residues from the core oligosaccharide. DMJ and 
SSN inhibit mannosidases I and II, respectively, and 
prevent trimming events that occur in the Golgi (for re- 
view see Elbein, 1987). In the presence of these trim- 
ming inhibitors, cleavage of GP-C was observed (Fig. 
3, data for SSN not shown). Quantitative estimates of 
the proportion of the incorporated radioactivity in GP-C 
and GP-2 in pulse and chase samples were made on 
the basis of densitometer scans of exposed films. Ta- 
ble 1 summarizes the analysis of the experiment de- 
10m Pulse Chase 
v c 0 15 30 60 so 120 180 270 360 
FIG. 2. Pulse-chase labeling of LCMV GP-C. BHK-21 ceils were 
infected with LCMV-Arm (m.o.i. 0.1). After 24 hr cultures were pulse 
labeled for 10 min with 35S-translabel (200 pglml). GP-C and GP-2 
were immunoprecipitated using MAb 33.6 as described under Mate- 
rials and Methods and analyzed on a 10% SDS-polyacrylamide gel. 
Cleavage of GP-C to yield GP-2 was first evident at 90 min in this 
experiment. V, pulse-labeled lysate incubated with guinea pig poly- 
clonal antiserum to LCMV. 
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FIG. 3. GP-C is not cleaved when glycosylation is prevented by 
incubation in the presence of TUN. Infected BHK cells were pulsed 
and chased in the presence of various inhibitors of glycosylation as 
described under Materials and Methods, then immunoprecipitated 
with MAb 33.6 that binds to both glycosylated and unglycosylated 
GP-C and GP-2. Appearance of GP-2 was indicative of cleavage of 
the GP-C precursor polypeptide. 
pitted in Fig. 3. The scan confirmed the observation 
that cleavage failed to occur in the TUN-treated cul- 
tures. Cleavage occurred in the presence of CSP, NM- 
DMJ, and DMJ, although CSP appeared to exhibit a 
slight inhibitory effect on processing as indicated by 
greater retention of label in GP-C in the chase samples. 
Thus, while addition of N-linked oligosaccharides is 
necessary for cleavage, processing is tolerant of varia- 
tions in the extent of trimming. 
Cleavage of GP-C occurs in the Golgi or 
post-Golgi compartment 
The data indicated that in the absence of glycosyla- 
tion, cleavage failed to occur because the protein was 
not transported to the site of cleavage, or perhaps be- 
cause the protein, although transported, was not 
folded in a conformation appropriate for proteolysis. To 
determine the intracellular location of GP-C cleavage 
we examined the temporal relationship between cleav- 
age and trimming by pulse-chase under conditions of 
reduced temperature which have been shown to halt 
the transport of viral proteins in defined compartments 
of the cell (Matlin and Simons, 1983; Saraste and Kuis- 
manen, 1984; Saraste et a/., 1986; Balch and Keller, 
1986; Copeland et a/., 1988). At 15”, proteins exit the 
rough endoplasmic reticulum, but are halted at a pre- 
Golgi compartment. At 20” proteins reach the trans- 
Golgi, as determined by the transition to complex car- 
bohydrate, but are not transported to the cell surface. 
Infected cells were pulsed for 1 hr at 37”, then chased 
at 15, 20, and 37” for 4 hr. Lysates were then immuno- 
precipitated with MAb 33.6 to determine whether 
cleavage had taken place. There was no evidence for 
cleavage at either 15 or 20” (Table 2). At both tempera- 
tures uncleaved GP-C remained EH sensitive, indicat- 
ing that GP-C did not reach the medial Golgi. To define 
the location more precisely, we repeated the experi- 
ments chasing at 15, 26 and 37” in order to find the 
lowest temperature where GP-C acquired EH resis- 
tance, and this occurred at 26”. As evident in Fig. 4, 
there was a small amount of GP-2 present when cells 
were chased at 15”, and this was likely due to cleavage 
of GP-C during the 1-hr pulse period. The bands in- 
creased markedly at 26 and 37”. During the pulse, and 
at both 15 and 26”, GP-C was sensitive to EH, as indi- 
cated by a shift in migration relative to control lanes. 
However, at 37”, GP-C was EH resistant, indicating ad- 
dition of terminal sugars. At all temperatures, GP-2 was 
resistant to EH. These results indicate that cleavage of 
GP-C to GP-1 and GP-2 must occur after trimming, that 
is, in the medial or trans-Golgi or later. Although cleav- 
age had occurred at 26”, a portion of GP-C was still 
EH sensitive, indicating that transport past the medial 
Golgi compartment was incomplete. At all tempera- 
tures, some full-length GP-C acquired EH resistance, 
suggesting that cleavage was not essential for trans- 
port of GP-C to the medial Golgi. 
Production of infectious virus is reduced 
in the presence of TUN 
The results of the above experiments indicated that 
GP-C was cleaved in the medial or trans-Golgi or later, 
and that in the absence of N-linked glycosylation GP-C 
was not cleaved. It seemed likely that this was because 
the unglycosylated proteins were not transported to 
the site of cleavage, but we could not exclude the pos- 
sibility that abnormal folding precluded recognition by 
TABLE 1 
QUANTITATIVE DISTRIBUTION OF LABEL BETWEEN GP-C AND GP-2 IN THE 
PRESENCE OF INHIBITORS OF GLYCOSYLATION 
Percentage of GP-C 
+ GP-2 Labela 
Inhibitor Sample GP-C GP-2 
Control Pulseb 98 2 
Chase” 40 60 
TUN Pulse 1 ood 0 
Chase 100 0 
CSP Pulse 100 0 
Chase 75 25 
NM-DNJ Pulse 100 0 
Chase 50 50 
DMJ Pulse 99 1 
Chase 25 75 
a Distribution of label in GP-C and GP-2 was estimated by quantita- 
tive densitometry of two autoradiographic exposures of the gel 
shown in Fig. 3. Total area under GP-C + GP-2 bands was normalized 
to 100%. Percentage distribution of exposure under each peak is 
shown. 
* Pulse label was for 1 hr with [%]methionine (60 pCi/ml) in Met- 
free medium. 
c Chase was for 4 hr in the presence of a 1 O-fold excess of unla- 
beled methionine. 
d Present as unglycosylated GP-C. 
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TABLE 2 
QUANTITATIVE DISTRIBUTIONOF LABELBETWEEN 
GP-CANDGP-~ATVARIOUSTEMPERATURES 
Percentage of 
GP-C and GP-2 
Labela 
Sample Temperature Endo H GP-C GP-2 
Pulse* 
Chasec 
Chase 
Chase 
Chase 
Pulse 
Chase 
Chase 
Chase 
Chase 
37” 100 0 
15” 94 6 
20” 95 5 
26” 83 16 
37” 54 46 
37” 
15” 
20” 
26” 
37” 
+ 96 4 
+ 94 6 
+ 93 7 
+ 78 22 
+ 54 46 
a Distribution of label in GP-C and GP-2 was estimated by quantita- 
tive densitometry of two autoradiographic exposures of the gel 
shown in Fig. 4. Total area under GP-C + GP-2 bands was normalized 
to 100%. Percentage distribution of exposure under each peak is 
shown. Data were pooled from two experiments. 
’ Pulse labeling was for 1 hr with 60 rCi/ml [35S]methronine in Met- 
free medium. 
c Chase period was 4 hr at the indicated temperature with 1 O-fold 
excess of [35S]methionine. 
the appropriate protease. As another measure of the 
effect of glycosylation inhibitors on transport, we as- 
sayed the production of infectious virus grown in the 
presence of TUN, SSN, or CSP. Supernates from in- 
fected BHK-21 cells were titered 48 hr after infection. 
Medium containing the drugs was changed once at 24 
hr, so the data represent virus released in the last 24 
hr of infection. Only TUN significantly reduced the 
amount of virus produced (Fig. 5). 
TUN prevents transport of LCMV glycoproteins 
To determine whether the reduction in infectivity was 
due to the production of noninfectious particles, or a 
EH + 
M P C C c M PC c I: 
37” 15" 26" 370 37" 15" 26" 37" 
-GPC 
+GP-2 
FIG. 4. Cleavage of GP-C occurs in the Golgi or post-Golgi compart 
ment. Infected BHK cells were pulsed for 1 hr at 37”, then chased for 
4 hr at the specified temperatures, before immunoprecipitation with 
MAb binding GP-C and GP-2. Half of each sample was treated with 
EH after immunoprecipitation as described under Materials and 
Methods. The other half was incubated in EH buffer without enzyme 
for the same time before SDSPAGE. 
r 
P 
% 
B Y 
FIG. 5. Replication of LCMV is reduced in the presence of TUN. 
BHK cells were infected with LCMV, then incubated for the duration 
of infection with TUN, CSP, SSN, or DMSO (control). Media were 
changed once after 24 hr and supernates were collected at 48 hr 
and assayed for infectious virus. 
failure to bud, we attempted to purify virus particles 
from infected cultures grown in TUN. We were unable 
to band virus in renograffin gradients prepared from su- 
pernatants of TUN-treated cultures. We also examined 
virus budding by electron microscopy and found that 
budding was inhibited in the presence of TUN, sug- 
gesting that the unglycosylated viral proteins were not 
reaching the surface of the cell (Fig. 6). This result was 
confirmed by immunofluorescence staining of viral pro- 
teins on the surfaces of infected BHK cells. We used a 
MAb against GP-1 which stained control virus-infected 
cells and also reacted with unglycosylated glycopro- 
teins in permeabilized cells treated with TUN. This MAb 
failed to detect any viral protein on the surfaces of TUN- 
treated cells (Fig. 7). Viral glycoproteins were evident at 
the surfaces of infected cells treated with the trimming 
inhibitors CSP and SSN in agreement with infectivity 
data. Thus we concluded from these studies that trans- 
port of the unglycosylated proteins to the cell surface 
was blocked. 
DISCUSSION 
Results presented in this paper address basic as- 
pects of glycosylation and proteolytic cleavage of the 
LCMV glycoprotein precursor, GP-C, and how these 
processes affect transport of viral proteins within the 
infected cell. We have shown that the mature structural 
glycoproteins, GP-1 and GP-2, of the Arm-4 strain of 
LCMV bear five and two N-linked complex carbohy- 
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FIG. 6. Budding of LCMV is inhibited in the presence of TUN. Monolayers of BHK cells were infected with LCMV and 
preset rice of TUN or DMSO (control) before fixation and examination by EM. No virions were evident budding from tun 
(panel s A and B), while numerous budding virions were seen in control cultures (panels C and D). Magnified 30,000X. 
grown for 24 hr in the 
licamycin-treated ( :ells 
drates, respectively. In previous studies we have 
shown that radiolabeled mannose and glucosamine 
were preferentially incorporated into GP-C, while the 
GP-1 and GP-2 cleavage products were labeled with 
glucosamine, galactose, and fucose but contained lit- 
tle residual mannose, suggesting that GP-C was a high 
mannose precursor (Buchmeier and Oldstone, 1979; 
Buchmeier and Parekh, 1987). When the role of glyco- 
sylation in post-translational events was examined, we 
found that appropriate folding of the glycoprotein, indi- 
cated using MAb which bind to conformational epi- 
topes, failed to occur without glycosylation (Wright et 
al., 1989). In the present study, we have demonstrated 
that cleavage and transport of GP-C also failed to occur 
when glycosylation was blocked by TUN. 
To determine how prevention of glycosylation 
affected cleavage, we needed to establish the tempo- 
ral sequence of oligosaccharide trimming and proteo- 
lytic cleavage of GP-C. As noted, GP-1 and GP-2 bear 
complex carbohydrates, but GP-C contains predomi- 
nantly mannose-rich core sugars. A quantitatively mi- 
nor fraction of GP-C does however contain fucose and 
galactose, indicative of mature N-linked oligosaccha- 
rides. Transition from high mannose carbohydrate to 
complex carbohydrate, measured by loss of sensitivity 
to EH and acquisition of terminal sugars, occurs in the 
medial Golgi (Balch and Keller, 1986). The results of our 
pulse-chase experiments suggest that cleavage oc- 
curs approximately 75-90 min after synthesis and after 
transport to the medial Golgi. These conclusions were 
strengthened in temperature block pulse-chase exper- 
iments. When infected cells were incubated at temper- 
atures known to halt protein transport at defined com- 
partments within the cell, we never observed EH sensi- 
tivity in the cleaved GP-2 molecule, indicating that 
transition to complex carbohydrates occurred before 
cleavage. Moreover, by temperature block experi- 
ments we localized the site of cleavage to the Golgi 
apparatus. In cells pulsed and then chased at 20”, no 
cleavage of GP-C was observed. When the chase was 
performed at 26”, a temperature which halts transport 
in the medial/trans-Golgi, we observed cleavage sim- 
ilar to that seen in cells chased at 37”. The reported 
sites of cleavage of precursor glycoproteins of other 
enveloped RNA viruses vary. In this respect, LCMV re- 
sembles most closely the paramyxoviruses, where the 
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FIG. 7. LCMV glycoproteins are not transported to the cell surface 
when glycosylation is blocked. BHK cells were infected, then rncu- 
bated In the presence of TUN for the duration of infection. Living cells 
were assayed for surface expression of GP-1 using MAb 67.2. Con- 
trol cells expressed GP-1 (A); TUN-treated cells did not (B). Infected 
BHK monolayers also incubated in TUN were permeabilized with ac- 
etone, then stained to visualize intracellular GP-C (C). 
F proteins are cleaved in the trans-Golgi or the immedi- 
ate trans-Golgi compartment (Sato et a/., 1988; Ya- 
mada et a/., 1988; Morrison et a/., 1985; Nagai et a/., 
1976). However, for measles virus, unlike LCMV, 
cleavage apparently continues at the cell surface (Ya- 
mada et al., 1988). 
There are two likely possibilities to explain how pre- 
vention of glycosylation interferes with cleavage of 
GP-C. Either the unglycosylated GP-C polypeptide 
chain aggregates in the RER and does not reach the 
site of cleavage or cleavage is dependent on a confor- 
mation which is not expressed in the unglycosylated 
molecule. Our results indicate that under conditions of 
TUN block, unglycosylated, uncleaved GP-C does not 
reach the ceil surface. Prevention of GP-C transport is 
reflected by both lack of viral glycoprotein staining at 
the cell surface and a failure to produce virions by bud- 
ding at the plasma membrane. Similar findings have 
been reported for feline and murine leukemia virus (Po- 
linoff et al., 1982; Pinter et a/., 1984), Mason-Pfizer 
monkey virus (Chatterjee et al., 1981) Junin virus (Pa- 
dula and de Martinez Segovia, 1984) bovine herpes 
virus (van Grunen-Littel-van den Hurk and Babiuk, 
1985) and vesicular stomatitis virus (VSV) (Leavitt et 
a/., 1977). For the latter, it was suggested that failure 
of transport was due to protein aggregation in the RER 
(Gibson et al., 1978, 1979). Unglycosylated envelope 
proteins of measles virus (Sato eta/., 1988) and Sendai 
virus (Mottet et al., 1986) also may remain in the RER. 
We observed accumulation of unglycosylated GP-C 
within cells in a form which was not recognized by anti- 
bodies to conformational epitopes on GP-C and GP-1 
(Wright et al., 1989). We attempted to demonstrate 
transport of unglycosylated GP-C in cells held at 30”, 
conditions under which unglycosylated VSV G protein 
is transported, but neither GP-C transport nor virion 
production was observed. On the basis of the accumu- 
lated evidence, it is likely that unglycosylated GP-C ag- 
gregates in the RER or pre-Golgi compartment and 
thus never reaches the site of proteolysis. 
To determine whether transport and cleavage were 
dependent upon oligosaccharide chain structure, we 
assessed cleavage in the presence of a variety of inhib- 
itors of oligosaccharide trimming. For some viruses, 
addition of the core oligosaccharides alone is not ade- 
quate for transport, and additional trimming of sugar 
moieties is required. Specifically, prevention of trim- 
ming of the outermost glucose moieties on the core 
oligosaccharide (Glc, Man 5-9 GlcNAc,) with either 
CSP or DNJ inhibits transport of the envelope glycopro- 
teins of murine retroviruses (Pinter et a/., 1984), murine 
hepatitisvirus (Repp eta/., 1985) and VSV (Schlesinger 
et a/., 1984) but has no effect on the transport of HA 
of influenza (Romero et a/., 1983; Burke et a/., 1984; 
Elbein et al., 1984) or of the envelope glycoprotein of 
RSV (Bosch and Schwarz, 1984). The same drugs re- 
duced infectivity of Sindbis not by preventing transport 
but by preventing cleavage of the glycoprotein precur- 
sor (Schlesinger et a/., 1985; McDowell et a/., 1987). 
For LCMV, we found that addition of the core oligosac- 
charide alone without any further processing was 
sufficient to allow transport, cleavage, and production 
of infectious particles. 
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Although we can correlate the absence of cleavage 
with reduced infectivity in these experiments, we do 
not know whether cleavage is necessary for transport 
to the plasma membrane. We do occasionally see 
small amounts of a glycoprotein comigrating with 
GP-C associated with mature virions, and others have 
reported a molecule the same size as GP-C on the sur- 
faces of infected cells (van der Zeijst eta/., 1983), sug- 
gesting that cleavage may not be an absolute require- 
ment for viral maturation. Relatively few experiments 
have been conducted in viral systems where the need 
for cleavage has been examined in the absence of 
drugs such as TUN or monensin that also effect trans- 
port. When cleavage of a glycoprotein precursor acti- 
vates fusion activity of the subunits, as is the case for 
many enveloped RNA viruses, absence of cleavage 
would reduce infectivity. This is true for Sendai virus 
(Scheid and Choppin, 1974, 1976), mammalian influ- 
enza viruses grown in avian cells (Klenk er al., 1975; 
Lazarowitz and Choppin, 1975; Kawaoka et al., 1984), 
and HIV-1 (McCune eta/., 1988). Heretofore, the glyco- 
proteins of LCMV have not been associated with mem- 
brane fusion activity. Efforts to further define the bio- 
synthetic pathways of the LCMV glycoproteins and 
their interaction in the virion structure are under way. 
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